Re: Sanofi partnership on MS?
Must be very depressing to have two drugs that work nicely but have such horrifying and almost certain side-effects. Must be very alluring to think of a nice Sarepta alternative RNA drug (or drugs) with no side effects and the same (or better) efficacy. That would make their MS platform so much nicer.
Someone posted one of our patents for a drug that attacks MS thru one approach (auto-immunity?). And perhaps we have other approaches already? And perhaps yet other possible targets up Wilton's sleeve? It may not just be one MS drug we come up with .... Kaye said we're going to focus on muscles. So it would seem our focusing on MS is going to be financed by someone else. Many see Sanofi/Genezyme as our future home ... or model for a merging with Sanofi. (I.e. me).... We may as well get that ball rolling now....